[go: up one dir, main page]

DE60213874D1 - Verfahren zur herstellung von protease hemmenden zwischenprodukten - Google Patents

Verfahren zur herstellung von protease hemmenden zwischenprodukten

Info

Publication number
DE60213874D1
DE60213874D1 DE60213874T DE60213874T DE60213874D1 DE 60213874 D1 DE60213874 D1 DE 60213874D1 DE 60213874 T DE60213874 T DE 60213874T DE 60213874 T DE60213874 T DE 60213874T DE 60213874 D1 DE60213874 D1 DE 60213874D1
Authority
DE
Germany
Prior art keywords
intermediate products
inhibiting intermediate
preparing protease
present
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60213874T
Other languages
English (en)
Other versions
DE60213874T2 (de
Inventor
Daniel Doan
D Davis
Claiborne Lovelace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of DE60213874D1 publication Critical patent/DE60213874D1/de
Publication of DE60213874T2 publication Critical patent/DE60213874T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Enzymes And Modification Thereof (AREA)
DE60213874T 2001-09-20 2002-09-16 Verfahren zur herstellung von protease hemmenden zwischenprodukten Expired - Fee Related DE60213874T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32369201P 2001-09-20 2001-09-20
US323692P 2001-09-20
PCT/US2002/029315 WO2003024974A2 (en) 2001-09-20 2002-09-16 Process for preparing protease inhibitor intermediates

Publications (2)

Publication Number Publication Date
DE60213874D1 true DE60213874D1 (de) 2006-09-21
DE60213874T2 DE60213874T2 (de) 2007-10-18

Family

ID=23260324

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60213874T Expired - Fee Related DE60213874T2 (de) 2001-09-20 2002-09-16 Verfahren zur herstellung von protease hemmenden zwischenprodukten

Country Status (8)

Country Link
US (1) US7145024B2 (de)
EP (1) EP1465897B1 (de)
JP (1) JP2005510467A (de)
AT (1) ATE335745T1 (de)
AU (1) AU2002326925A1 (de)
DE (1) DE60213874T2 (de)
ES (1) ES2265052T3 (de)
WO (1) WO2003024974A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1532127E (pt) * 2002-06-27 2007-01-31 Smithkline Beecham Corp Preparação de estereoisómeros de ( 3alfa, 3alfa/beta, 6alfa/beta )hexa-hidrofuro ( 2,3-b ) furan-3-ol
WO2004060895A1 (ja) * 2002-12-27 2004-07-22 Sumitomo Chemical Company, Limited ヘキサヒドロフロフラノール誘導体の製造方法、その中間体及びその製造方法
US20060148865A1 (en) * 2003-06-27 2006-07-06 Martin Michael T Preparation of chemical compounds
RU2464266C2 (ru) 2006-11-09 2012-10-20 Тиботек Фармасьютикалз Лтд. СПОСОБЫ ПОЛУЧЕНИЯ ГЕКСАГИДРОФУРО[2,3-b] ФУРАН-3-ОЛА
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
BR112012018862A2 (pt) 2010-01-28 2015-10-13 Mapi Pharma Ltd processo para a preparação de darunavir e intermediários de darunavir
US9125625B2 (en) 2010-06-10 2015-09-08 The Regents Of The University Of California Textile-based printable electrodes for electrochemical sensing
PL2643326T3 (pl) 2010-11-23 2017-06-30 Mylan Laboratories, Limited Sposób przygotowania (3R, 3aS, 6aR)-heksahydrofuro[2,3-b]furan-3-olu
CN104114224A (zh) 2011-09-02 2014-10-22 加利福尼亚大学董事会 用于生物传感和药物递送的微针阵列
CN106977526A (zh) * 2017-05-25 2017-07-25 河南省商业科学研究所有限责任公司 一种3,4‑二甲基噻吩[2,3‑b]并噻吩的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6828894A (en) * 1993-05-14 1994-12-12 Merck & Co., Inc. Hiv protease inhibitors
US5810766A (en) 1995-02-28 1998-09-22 Chiron Vision Corporation Infusion/aspiration apparatus with removable cassette

Also Published As

Publication number Publication date
JP2005510467A (ja) 2005-04-21
WO2003024974A3 (en) 2004-07-29
ATE335745T1 (de) 2006-09-15
WO2003024974A2 (en) 2003-03-27
DE60213874T2 (de) 2007-10-18
AU2002326925A1 (en) 2003-04-01
US20040204595A1 (en) 2004-10-14
EP1465897A2 (de) 2004-10-13
EP1465897B1 (de) 2006-08-09
US7145024B2 (en) 2006-12-05
ES2265052T3 (es) 2007-02-01

Similar Documents

Publication Publication Date Title
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
WO2004096818A3 (en) Method and compositions for identifying anti-hiv therapeutic compounds
DE60110106D1 (de) Verfahren zur herstellung von pankreasenzym enthaltende mikrosphären mit hoher stabilität
ATE529409T1 (de) Verfahren zur herstellung von kristallinen aripiprazolformen
ATE354648T1 (de) Verfahren zur herstellung eines virus inaktivierten thrombin präparates
ATE440078T1 (de) Verfahren zur herstellung von alkylaminen
ATE430160T1 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
DE60330146D1 (de) Verfahren zur reinigung von fibrinogen
DE60213874D1 (de) Verfahren zur herstellung von protease hemmenden zwischenprodukten
ATE472251T1 (de) Verfahren zur fruchtausdünnung
ATE321850T1 (de) Verfahren zur herstellung von polynucleotivarianten
TW200517121A (en) Immunogen
TW200726479A (en) Method of inducing neutralizing antibodies to human immunodeficiency virus
ATE204851T1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
DE60124289D1 (de) Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
ATE404577T1 (de) Verfahren zur herstellung von eplerenon
DE60219927D1 (de) Verfahren zur herstellung von glycopeptid- phosphonat-derivaten
DE60231475D1 (de) Materialien und methoden zur behandlung von hepatitis c
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
DE602004031129D1 (de) Verfahren zur herstellung von quetiapin
DE50112449D1 (de) Verfahren zur herstellung von 3,3-diarylpropylaminen
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
WO2007002172A3 (en) Hiv-1 protease inhibitors
ATE272038T1 (de) Verfahren zur herstellung von 2-alkyl-3- chlorphenolen
DE50112690D1 (de) Verfahren zur aufbereitung von pyrrolidon- und n-vinylpyrrolidon-rückständen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee